Parkinson's disease and COVID-19: a systematic review and meta-analysis.

Reza Jalili KhoshnoodAlireza ZaliArash TafreshinejadMahsa GhajarzadehNarges EbrahimiSaeid SafariOmid Mirmosayyeb

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

The results of this systematic review and meta-analysis show that the pooled prevalence of COVID-19 infection in PD cases is 5% besides hospitalization and mortality rates which are 49% and 12%.

Keyphrases

risk factors
coronavirus disease
sars cov
cardiovascular events
randomized controlled trial
clinical trial
type diabetes
study protocol